Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Detection of BRAF V600E mutation in metastatic colorectal carcinoma : A QuIP round robin test].

Der Pathologe - 1 Mar 2022

Jöhrens Korinna, Fischer Josephine, Möbs Markus, Junker Klaus, Kirfel Jutta, Perner Sven, Laßmann Silke, Werner Martin, Borgmann Vanessa, Bläker Hendrik, Hummel Michael

Abstract excerpt

Round robin testing is an important instrument for quality assurance. Increasingly, this also applies to the results of molecular diagnostics in pathology, which directly influence therapy decisions in precision oncology. In metastatic colorectal carcinoma (mCRC), the focus has been on detecting KRAS and NRAS mutations, whose absence allows therapy with EGFR blocking antibodies. Recently, BRAF has been added as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Precision Medicine

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 34807276
DOI: 10.1007/s00292-021-01022-8
PMCID: PMC8888471

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Detection of BRAF V600E mutation in metastatic colorectal carcinoma : A QuIP round robin test].PMID 34807276Read ↗

Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.Semantic proximity Read ↗

[BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version].Semantic proximity Read ↗

BRAF mutation testing in colorectal cancer.Semantic proximity Read ↗

A multicenter survey on BRAF screening for the implementation of perioperative cancer genomic medicine for resectable colorectal oligometastases.Semantic proximity Read ↗

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.Semantic proximity Read ↗

Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma.Semantic proximity Read ↗

Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer: a case report.Semantic proximity Read ↗

Molecular genetics external quality assessment pilot scheme for KRAS analysis in metastatic colorectal cancer.Semantic proximity Read ↗

Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.Semantic proximity Read ↗

Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer.Semantic proximity Read ↗

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.Semantic proximity Read ↗

Diagnostic value of immunohistochemistry for the detection of the BRAF V600E mutation in colorectal carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.